Table 2.
Methodological strategies to check for neurovascular confounding in pharmacological-functional imaging studies.
Example references | |
---|---|
Global physiological–psychological indices | |
Systemic physiological measurements – pulse, blood pressure: compare between sessions; or include as regressors of no interest | Kukolja et al. (2009) |
Subjective scores (e.g. Bond and Lader, 1974) – as for physiological parameters | Thiel et al. (2001) |
Co-administration of drug that counteracts extracerebral cardiovascular side-effects, e.g. glycopyrrolate with centrally acting cholinesterase inhibitor | Furey et al. (2000a) |
Mean rCBF/BOLD values | |
Grand mean rCBF or BOLD values – over whole brain per session; compare between sessions and/or correct (scaling) | Grasby et al. (1995); most fMRI studies |
Global mean BOLD values – over whole brain per scan; include as regressor of no interest or correct (scaling) | Thiel et al. (2001) |
High-pass filtering – removes gradual changes in response, e.g. due to declining drug levels | Most fMRI studies |
Voxel-level session effect; compare across conditions | Bentley et al. (2004) |
Drug × condition interactions | |
Dissociations: identify interactions with similar activation levels between conditions under placebo (e.g. placebo: A – low; B – low; drug: A – low; B – high) | Bentley et al. (2004) |
Cross-over: identify interactions in which drug causes an opposite pattern of responses across conditions (i.e. placebo: A – high; B – low; drug: A – low; B – high) | Hahn et al. (2007), Kukolja et al. (2009) |
Cross-over re-mapping: e.g. where drug modulates differential responses to two arbitrary stimuli whose cognitive significance reverses in half of subjects | Thiel et al. (2002a) |
Region-specific interactions, e.g. task-specific drug interaction in parietal but not occipital cortex despite similar activation levels under placebo | Thiel et al. (2001), Sperling et al. (2002) |
Behavioral correlations | |
Correlation of drug-induced activation change and behavioural measure of interest suggests drug effect on neural activity, especially if scan and behavioural measure separated in time | Furey et al. (2000b), Bentley et al. (2009) |
Alternative analytic methods | |
Modelling multiple basis functions for BOLD response | Rombouts et al. (2005) |
Measurement of BOLD phase relationship only with respect to alternating visual stimulus | Silver et al. (2008) |
Fractal complexity (Hurst exponent, H) and inter-regional correlations of resting-state fMRI time-series | Wink et al. (2006), Suckling et al. (2008) |
Inter-regional correlations of event-related fMRI (functional connectivity) | Jacobsen et al. (2004), Kobiella et al. (2011) |
Measurement of BOLD and rCBF | |
Use of arterial-spin labelling in addition to T2* MRI sequences | Hahn et al. (2009) |